225 related articles for article (PubMed ID: 9569035)
21. A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families.
Llovet P; Illana FJ; Martín-Morales L; de la Hoya M; Garre P; Ibañez-Royo MD; Pérez-Segura P; Caldés T; García-Barberán V
Fam Cancer; 2017 Oct; 16(4):567-575. PubMed ID: 28573494
[TBL] [Abstract][Full Text] [Related]
22. High frequency of germline p53 mutations in childhood adrenocortical cancer.
Wagner J; Portwine C; Rabin K; Leclerc JM; Narod SA; Malkin D
J Natl Cancer Inst; 1994 Nov; 86(22):1707-10. PubMed ID: 7966399
[TBL] [Abstract][Full Text] [Related]
23. A germline 2.35 kb deletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family.
Plummer SJ; Santibáñez-Koref M; Kurosaki T; Liao S; Noble B; Fain PR; Anton-Culver H; Casey G
Oncogene; 1994 Nov; 9(11):3273-80. PubMed ID: 7936651
[TBL] [Abstract][Full Text] [Related]
24. A novel, de novo germline TP53 mutation in a rare presentation of the Li-Fraumeni syndrome in the maxilla.
Patrikidou A; Bennett J; Abou-Sleiman P; Delhanty JD; Harris M
Oral Oncol; 2002 Jun; 38(4):383-90. PubMed ID: 12076704
[TBL] [Abstract][Full Text] [Related]
25. A new germline TP53 gene mutation in a family with Li-Fraumeni syndrome.
Dockhorn-Dworniczak B; Wolff J; Poremba C; Schäfer KL; Ritter J; Gullotta F; Jürgens H; Böcker W
Eur J Cancer; 1996 Jul; 32A(8):1359-65. PubMed ID: 8869100
[TBL] [Abstract][Full Text] [Related]
26. [A method for detection of germinal mutations in the p53 tumor suppressor gene].
Sedlácek Z; Kríz V; Seemanová E; Vlcek C; Maríková T; Mares J; Goetz P
Cas Lek Cesk; 1996 Dec; 135(23):762-7. PubMed ID: 9005123
[TBL] [Abstract][Full Text] [Related]
27. Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors.
Varley JM; McGown G; Thorncroft M; James LA; Margison GP; Forster G; Evans DG; Harris M; Kelsey AM; Birch JM
Am J Hum Genet; 1999 Oct; 65(4):995-1006. PubMed ID: 10486318
[TBL] [Abstract][Full Text] [Related]
28. RNA polymerase III transcription can be derepressed by oncogenes or mutations that compromise p53 function in tumours and Li-Fraumeni syndrome.
Stein T; Crighton D; Boyle JM; Varley JM; White RJ
Oncogene; 2002 May; 21(19):2961-70. PubMed ID: 12082526
[TBL] [Abstract][Full Text] [Related]
29. Exclusion of a p53 germline mutation in a classic Li-Fraumeni syndrome family.
Evans SC; Mims B; McMasters KM; Foster CJ; deAndrade M; Amos CI; Strong LC; Lozano G
Hum Genet; 1998 Jun; 102(6):681-6. PubMed ID: 9703430
[TBL] [Abstract][Full Text] [Related]
30. p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome.
Quesnel S; Verselis S; Portwine C; Garber J; White M; Feunteun J; Malkin D; Li FP
Oncogene; 1999 Jul; 18(27):3970-8. PubMed ID: 10435620
[TBL] [Abstract][Full Text] [Related]
31. Three germline mutations in the TP53 gene.
Cornelis RS; van Vliet M; van de Vijver MJ; Vasen HF; Voute PA; Top B; Khan PM; Devilee P; Cornelisse CJ
Hum Mutat; 1997; 9(2):157-63. PubMed ID: 9067756
[TBL] [Abstract][Full Text] [Related]
32. p53 Germline mutation in a patient with Li-Fraumeni Syndrome and three metachronous malignancies.
Pötzsch C; Voigtländer T; Lübbert M
J Cancer Res Clin Oncol; 2002 Aug; 128(8):456-60. PubMed ID: 12200603
[TBL] [Abstract][Full Text] [Related]
33. p53 Testing for Li-Fraumeni and Li-Fraumeni-like syndromes.
Gonzalez K; Fong C; Buzin C; Sommer SS; Saldivar JS
Curr Protoc Hum Genet; 2008 Apr; Chapter 10():Unit 10.10. PubMed ID: 18428420
[TBL] [Abstract][Full Text] [Related]
34. [When is it useful to look for TP53 germline gene mutations in families of oncology patients?].
Trková M; Sedlácek Z
Cas Lek Cesk; 2003; 142(4):220-5. PubMed ID: 12841124
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of germline TP53 mutations and history of Li-Fraumeni syndrome in families with childhood adrenocortical tumors, choroid plexus tumors, and rhabdomyosarcoma: a population-based survey.
Magnusson S; Gisselsson D; Wiebe T; Kristoffersson U; Borg Å; Olsson H
Pediatr Blood Cancer; 2012 Nov; 59(5):846-53. PubMed ID: 22653678
[TBL] [Abstract][Full Text] [Related]
36. A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li-Fraumeni patients carrying a mutation to the TP53 gene.
Varley JM; Thorncroft M; McGown G; Appleby J; Kelsey AM; Tricker KJ; Evans DG; Birch JM
Oncogene; 1997 Feb; 14(7):865-71. PubMed ID: 9047394
[TBL] [Abstract][Full Text] [Related]
37. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families.
Varley JM; McGown G; Thorncroft M; Santibanez-Koref MF; Kelsey AM; Tricker KJ; Evans DG; Birch JM
Cancer Res; 1997 Aug; 57(15):3245-52. PubMed ID: 9242456
[TBL] [Abstract][Full Text] [Related]
38. Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin.
Bendig I; Mohr N; Kramer F; Weber BH
Cancer Genet Cytogenet; 2004 Oct; 154(1):22-6. PubMed ID: 15381368
[TBL] [Abstract][Full Text] [Related]
39. Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations.
Krutilkova V; Trkova M; Fleitz J; Gregor V; Novotna K; Krepelova A; Sumerauer D; Kodet R; Siruckova S; Plevova P; Bendova S; Hedvicakova P; Foreman NK; Sedlacek Z
Eur J Cancer; 2005 Jul; 41(11):1597-603. PubMed ID: 15925506
[TBL] [Abstract][Full Text] [Related]
40. Absence of germline mutations in exons 5-9 of the p53 gene in patients with Li-Fraumeni-like (SBLA) and familial adenomatous polyposis heritable cancer syndromes.
Moore SK; Zambrano N; Lynch HT; Lipkin M; Kopelovich L
Cancer Genet Cytogenet; 1996 Sep; 90(2):125-9. PubMed ID: 8830720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
